Covid-19 and COPD: A tale of the two largest populous countries
On 16 May 2020, China and India reached to a common stage where the number of Covid-19 patients was found to be almost equal, with different death counts caused by Covid-19. The severity of Covid-19 was analyzed in these countries and compared with chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease characterized by airflow obstruction that is mostly constrained to developing countries. Covid-19 and COPD data were taken from World Health Organization (WHO), Geneva, Switzerland open databases. The mortality rate of Covid-19 was found higher in China than India. COPD mortality rate and death counts were almost equal in both countries. COPD mortality rate and death counts were higher than Covid-19 mortality in China and India. The average monthly deaths caused by COPD in China and India were found to be 16 and 24 times higher than the total deaths caused by Covid-19 until 16 May 2020, respectively. The result showed that COPD was more severe than Covid-19 and needed more attention and due importance.